Logo image of NZP.CA

CHATHAM ROCK PHOSPHATE LTD (NZP.CA) Stock Fundamental Analysis

TSX-V:NZP - TSX Venture Exchange - CA1621631094 - Common Stock - Currency: CAD

0.065  +0.02 (+30%)

Fundamental Rating

1

NZP gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 30 industry peers in the Chemicals industry. Both the profitability and financial health of NZP have multiple concerns. NZP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NZP has reported negative net income.
In the past year NZP has reported a negative cash flow from operations.
In the past 5 years NZP always reported negative net income.
In the past 5 years NZP always reported negative operating cash flow.
NZP.CA Yearly Net Income VS EBIT VS OCF VS FCFNZP.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -500K -1M -1.5M -2M

1.2 Ratios

With a Return On Assets value of -17.18%, NZP is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
NZP has a Return On Equity (-17.88%) which is in line with its industry peers.
Industry RankSector Rank
ROA -17.18%
ROE -17.88%
ROIC N/A
ROA(3y)-18.81%
ROA(5y)-16.3%
ROE(3y)-20.47%
ROE(5y)-17.47%
ROIC(3y)N/A
ROIC(5y)N/A
NZP.CA Yearly ROA, ROE, ROICNZP.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400 -500

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NZP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NZP.CA Yearly Profit, Operating, Gross MarginsNZP.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100K -200K -300K -400K

More info and screens

3

2. Health

2.1 Basic Checks

NZP has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NZP has more shares outstanding
NZP has a better debt/assets ratio than last year.
NZP.CA Yearly Shares OutstandingNZP.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
NZP.CA Yearly Total Debt VS Total AssetsNZP.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

An Altman-Z score of 8.06 indicates that NZP is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 8.06, NZP belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that NZP is not too dependend on debt financing.
NZP's Debt to Equity ratio of 0.00 is amongst the best of the industry. NZP outperforms 90.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 8.06
ROIC/WACCN/A
WACCN/A
NZP.CA Yearly LT Debt VS Equity VS FCFNZP.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

2.3 Liquidity

NZP has a Current Ratio of 0.47. This is a bad value and indicates that NZP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of NZP (0.47) is worse than 66.67% of its industry peers.
A Quick Ratio of 0.47 indicates that NZP may have some problems paying its short term obligations.
The Quick ratio of NZP (0.47) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.47
NZP.CA Yearly Current Assets VS Current LiabilitesNZP.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 48.91% over the past year.
Looking at the last year, NZP shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)48.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.21%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NZP.CA Yearly Revenue VS EstimatesNZP.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 1K 2K 3K 4K 5K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NZP. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NZP.CA Price Earnings VS Forward Price EarningsNZP.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NZP.CA Per share dataNZP.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

NZP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHATHAM ROCK PHOSPHATE LTD

TSX-V:NZP (6/6/2025, 7:00:00 PM)

0.065

+0.02 (+30%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)07-28 2025-07-28
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.1%
Ins Owner ChangeN/A
Market Cap7.12M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.09
P/tB 1.09
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.18%
ROE -17.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-18.81%
ROA(5y)-16.3%
ROE(3y)-20.47%
ROE(5y)-17.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.47
Quick Ratio 0.47
Altman-Z 8.06
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.21%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y41.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.98%
OCF growth 3YN/A
OCF growth 5YN/A